MTI-31
UNII RM15YYQ1CI

Substance Identification & Data

This profile provides standardized clinical and technical data for Mti-31, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RM15YYQ1CI.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1567915-38-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
RM15YYQ1CI
CAS Registry Number
1567915-38-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MTI-31
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C26H30N6O3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
LVPBYQVQBZLDAU-DZIBYMRMSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C1N([C@H](COC1)C)c2nc3c(ccc(-c4cc(ccc4)C(NC)=O)n3)c(N5C6COCC5CC6)n2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mti-31. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

MTORC 1/2 INHIBITOR LXI-15029

Systematic Nomenclature

BENZAMIDE, N-METHYL-3-(2-((3S)-3-METHYL-4-MORPHOLINYL)-4-(3-OXA-8-AZABICYCLO(3.2.1)OCT-8-YL)PYRIDO(2,3-D)PYRIMIDIN-7-YL)-

Technical Codes

LXI-15029
MTI-31
SCC-31